Skip to main navigation Skip to search Skip to main content

Atypical chronic myeloid leukemia (CML) with ETV6-ABL1 mutation managed successfully with a third-generation TKI and hematopoietic stem cell transplant

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)147-149
Number of pages3
JournalLeukemia and Lymphoma
Volume66
Issue number1
DOIs
StatePublished - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this